Paxlovid use was associated with lower rates of hospitalization and death, particularly among older adults, a new study finds.

It’s been estimated that about 400 million people worldwide have had long COVID. Some researchers say that number is much ...

Image Credit: Ariya J/Shutterstock.com In a recent study published in Communications Medicine, researchers examined the impact of an extended course of oral nirmatrelvir/ritonavir (Paxlovid ...

In hospitalized COVID-19 patients, azvudine shows lower all-cause mortality and fewer adverse events than Paxlovid, with ...

A widely available antiviral medication offers new possibilities for long Covid patients seeking relief from debilitating ...

Can Paxlovid treat long COVID? A new report suggests it might help some patients, but which patients might benefit remains unclear. The report, published last week in the journal Communications ...

Despite Previous Data, Paxlovid May Be Useful for Long Covid After All By Dennis Thompson HealthDay Reporter WEDNESDAY, Jan. 8, 2024 (HealthDay News) -- The antiviral pill Paxlovid might help some ...

Financial support options for Paxlovid are changing, but remain in place this winter for Medicare recipients and for others who can’t afford copays and cost-sharing. Patients are reporting ...

Some long COVID patients who took an extended course of Paxlovid saw temporary or lasting improvement, according to a small new case series published in the journal Communications Medicine.

Sky Force box office collection day 5: The aerial action drama is inching towards the ₹100-crore mark despite a drop in earnings during the midweek. Akshay Kumar and Veer Pahariya's Sky Force ...

It has now been over six months since the FDA authorized Paxlovid in December 2021 “for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older ...

US biotech Enanta Pharma has filed a lawsuit against Pfizer, claiming that its oral antiviral for COVID-19 Paxlovid infringes one of its patents and seeking damages from the pharma giant.